Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies.

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a serious adverse event associated with calcineurin inhibitors used for graft-versus-host disease (GVHD) prophylaxis. We compared the incidence of PRES in children with thalassemia (n = 222, 1.4 to 17.8 years old) versus sickle cell disease (SCD; n = 59, 2 to 17 years old) who underwent hematopoietic… (More)
DOI: 10.1016/j.bbmt.2017.05.033

Topics

Cite this paper

@article{Gaziev2017PosteriorRE, title={Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies.}, author={Javid Gaziev and Simone Marziali and Katia Paciaroni and Antonella Isgr{\`o} and Francesca Di Giuliano and Giorgia V. Rossi and Marco Marziali and Gioia De Angelis and Cecilia Alfieri and Michela Ribersani and M. Andreani and Maria Giuseppina Palmieri and Fabio Placidi and Andrea Romigi and Francesca Izzi and Roberto Floris and Nicola Biagio Mercuri}, journal={Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation}, year={2017}, volume={23 9}, pages={1531-1540} }